Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W T Friedewald

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Terapevticheskii Arkhiv|January 1, 1987
[Experience and outlook in the prevention of cardiovascular diseases in the USA]W T Friedewald
Statistics in Medicine|January 1, 1990
Costs of clinical trials and the need for efficiency: a brief overviewW T Friedewald
Public Health Reports (Washington, D.C. : 1974)|March 1, 1985
Physical activity research and coronary heart diseaseW T Friedewald
Journal of the American Dietetic Association|January 1, 1982
Current nutrition issues in hypertensionW T Friedewald
Circulation|June 1, 1983
Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trialsW T Friedewald
Medical Section Proceedings : the ... Annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting|January 1, 1991
Atherosclerosis: is there such a thing as regressionW T Friedewald
Statistical Bulletin (Metropolitan Life Insurance Company : 1984)|January 1, 1994
International comparisons of mortality ratesW T Friedewald
Circulation|July 1, 1978
Aspirin and coronary deathsW T Friedewald
Annals of Internal Medicine|May 1, 1972
Clofibrate in ischemic heart diseaseW T Friedewald, M Halperin
Circulation|January 1, 1982
Clinical trialsW T Friedewald, C D Furberg
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Terapevticheskii Arkhiv|January 1, 1987
[Experience and outlook in the prevention of cardiovascular diseases in the USA]W T Friedewald
Statistics in Medicine|January 1, 1990
Costs of clinical trials and the need for efficiency: a brief overviewW T Friedewald
Public Health Reports (Washington, D.C. : 1974)|March 1, 1985
Physical activity research and coronary heart diseaseW T Friedewald
Journal of the American Dietetic Association|January 1, 1982
Current nutrition issues in hypertensionW T Friedewald
Circulation|June 1, 1983
Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trialsW T Friedewald
Medical Section Proceedings : the ... Annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting|January 1, 1991
Atherosclerosis: is there such a thing as regressionW T Friedewald
Statistical Bulletin (Metropolitan Life Insurance Company : 1984)|January 1, 1994
International comparisons of mortality ratesW T Friedewald
Circulation|July 1, 1978
Aspirin and coronary deathsW T Friedewald
Annals of Internal Medicine|May 1, 1972
Clofibrate in ischemic heart diseaseW T Friedewald, M Halperin
Circulation|January 1, 1982
Clinical trialsW T Friedewald, C D Furberg
Pageof 3